Maraviroc
Back to searchMolecule Structure
Scientific Name
Maraviroc
Description of the Drug
Maraviroc is a CCR5 co-receptor antagonist used with other antiretroviral medications to treat CCR5-tropic HIV-1 infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04835
http://www.drugbank.ca/drugs/DB04835
Brand Name(s)
Celsentri, Selzentry
Company Owner(s)
Viiv Healthcare Co, Hetero Labs Ltd Unit Iii
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| C-C chemokine receptor type 5 | SINGLE PROTEIN | ANTAGONIST | CHEMBL274 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL51991 | |
| DrugBank | DB04835 | |
| PubChem: Thomson Pharma | 16284914 | |
| PDBe | MRV | |
| BindingDB | 50334986 | |
| rxnorm | SELZENTRY | MARAVIROC |
| PubChem: Drugs of the Future | 12015618 | |
| ChEBI | 63608 | |
| ZINC | ZINC000100003902 |
